FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jacques Rossouw

Research Profile

Procedures

Physiology

Postmenopause

Chemicals & Drugs

Concepts & Ideas

Disorders

Living Beings

Clinical Trials Data Monitoring Committees

Co-author Network

Publications

TOP 3
Jacques E Rossouw; Andrew M Kaunitz; JoAnn E Manson; Garnet L Anderson
Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.
Jacques E Rossouw; Maurizio Trevisan; Matthew Allison; Aaron Aragaki; Charles Eaton; Judith Hsia; Rebecca Jackson; Karen C Johnson; Lewis Kuller; JoAnn E Manson; Lisa W Martin; Ross L Prentice; Ron C Hoogeveen
Relationships of coronary heart disease with 27-hydroxycholesterol, low-density lipoprotein cholesterol, and menopausal hormone therapy.
Jacques E Rossouw; Per Morten Sandset; Sylvia Wasserthal-Smoller; Mary Cushman; Karen C Johnson; Lewis Kuller; Kamakshi Lakshminarayan; JoAnn E Manson; Lisa W Martin; José G Merino; Mary Pettinger; Frits Rosendaal; Jan Rosing; John Lynch
Tissue factor pathway inhibitor, activated protein C resistance, and risk of ischemic stroke due to postmenopausal hormone therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jacques Rossouw (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jacques E Rossouw; Andrew M Kaunitz; JoAnn E Manson; Garnet L Anderson
Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.
Obstetrics and gynecology 2013;121(1):172-6.
2012: Jacques E Rossouw; Maurizio Trevisan; Matthew Allison; Aaron Aragaki; Charles Eaton; Judith Hsia; Rebecca Jackson; Karen C Johnson; Lewis Kuller; JoAnn E Manson; Lisa W Martin; Ross L Prentice; Ron C Hoogeveen
Relationships of coronary heart disease with 27-hydroxycholesterol, low-density lipoprotein cholesterol, and menopausal hormone therapy.
Circulation 2012;126(13):1577-86.
2012: Jacques E Rossouw; Per Morten Sandset; Sylvia Wasserthal-Smoller; Mary Cushman; Karen C Johnson; Lewis Kuller; Kamakshi Lakshminarayan; JoAnn E Manson; Lisa W Martin; José G Merino; Mary Pettinger; Frits Rosendaal; Jan Rosing; John Lynch
Tissue factor pathway inhibitor, activated protein C resistance, and risk of ischemic stroke due to postmenopausal hormone therapy.
Stroke; a journal of cerebral circulation 2012;43(4):952-7.
2012: Jacques E Rossouw; Andrew M Kaunitz; JoAnn E Manson; Marcia L Stefanick
Study had insufficient power to investigate safety.
BMJ (Clinical research ed.) 2012;345():e8146; author reply e8164.
2012: Ying Huang; Anne McTiernan; Ulrike Peters; Dennis G Ballinger; Erica Beilharz; Rowan T Chlebowski; David R Cox; James Y Dai; David Hinds; Thomas Rohan; Jacques E Rossouw; Ross L Prentice
Genetic variants in the MRPS30 region and postmenopausal breast cancer risk.
Genome medicine 2012;4(3):19.
2011: Emily D Szmuilowicz; Mara Z Vitolins; Chunyuan Wu; Marcia L Stefanick; Matthew Allison; Robert Brzyski; Nancy C Greep; Diederick E Grobbee; Barbara V Howard; Karen C Johnson; JoAnn E Manson; Karen L Margolis; Judith K Ockene; Mary J O'Sullivan; Beatriz L Rodriguez; Jacques E Rossouw; Gloria E Sarto; Ellen W Seely
Vasomotor symptoms and cardiovascular events in postmenopausal women.
Menopause (New York, N.Y.) 2011;18(6):603-10.
2011: Ross L Prentice; Jacques E Rossouw
"Preventing breast cancer in postmenopausal women by achievable diet modification: a missed opportunity in public health policy" (Dayal HH and Kalia A, The Breast 2010; 19: 309-311).
Breast (Edinburgh, Scotland) 2011;20(1):99.
2011: Ying Huang; Anne McTiernan; Ulrike Peters; Dennis G Ballinger; Erica Beilharz; Rowan T Chlebowski; David R Cox; James Y Dai; David Hinds; Thomas E Rohan; Jacques E Rossouw; Ross L Prentice
Genetic variants in the MRPS30 region and postmenopausal breast cancer risk.
Genome medicine 2011;3(6):42.
2010: Hyeon Chang Kim; Philip Greenland; Jacques E Rossouw; JoAnn E Manson; Barbara B Cochrane; Norman L Lasser; Marian C Limacher; Donald M Lloyd-Jones; Karen L Margolis; Jennifer G Robinson
Multimarker prediction of coronary heart disease risk: the Women's Health Initiative.
Journal of the American College of Cardiology 2010;55(19):2080-91.
2010: Ross L Prentice; Sophie Paczesny; Aaron Aragaki; Lynn M Amon; Lin Chen; Sharon J Pitteri; Martin McIntosh; Pei Wang; Tina Buson Busald; Judith Hsia; Rebecca D Jackson; Jacques E Rossouw; JoAnn E Manson; Karen Johnson; Charles Eaton; Samir M Hanash
Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling.
Genome medicine 2010;2(7):48.
2010: Ross L Prentice; Ying Huang; David Hinds; Ulrike Peters; David R Cox; Erica Beilharz; Rowan T Chlebowski; Jacques E Rossouw; Bette Caan; Dennis G Ballinger
Variation in the FGFR2 gene and the effect of a low-fat dietary pattern on invasive breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(1):74-9.
2009: Ross L Prentice; Ying Huang; David Hinds; Ulrike Peters; Mary Pettinger; David R Cox; Erica Beilharz; Rowan T Chlebowski; Jacques E Rossouw; Bette Caan; Dennis G Ballinger
Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(11):3079-85.
2009: Sharon J Pitteri; Samir M Hanash; Aaron Aragaki; Lynn M Amon; Lin Chen; Tina Busald Buson; Sophie Paczesny; Hiroyuki Katayama; Hong Wang; Melissa M Johnson; Qing Zhang; Martin McIntosh; Pei Wang; Charles Kooperberg; Jacques E Rossouw; Rebecca D Jackson; JoAnn E Manson; Judith Hsia; Simin Liu; Lisa Martin; Ross L Prentice
Postmenopausal estrogen and progestin effects on the serum proteome.
Genome medicine 2009;1(12):121.
2008: Jacques E Rossouw; Mary Cushman; Philip Greenland; Donald M Lloyd-Jones; Paul Bray; Charles Kooperberg; Mary Pettinger; Jennifer Robinson; Susan Hendrix; Judith Hsia
Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy.
Archives of internal medicine 2008;168(20):2245-53.
2008: Matthew A Allison; JoAnn E Manson; Robert D Langer; John Carr; Jacques E Rossouw; Mary B Pettinger; Lawrence S Phillips; Barbara B Cochrane; Charles B Eaton; Philip Greenland; Susan Hendrix; Judith Hsia; Julie R Hunt; Rebecca D Jackson; Karen C Johnson; Lewis H Kuller; Jennifer Robinson
Oophorectomy, hormone therapy, and subclinical coronary artery disease in women with hysterectomy: the Women's Health Initiative coronary artery calcium study.
Menopause (New York, N.Y.) 2008;15(4 Pt 1):639-47.
2008: Ross L Prentice; Rowan T Chlebowski; Marcia L Stefanick; JoAnn E Manson; Robert D Langer; Mary Pettinger; Susan Hendrix; F Allan Hubbell; Charles Kooperberg; Lewis H Kuller; Dorothy S Lane; Anne McTiernan; Mary J O'Sullivan; Jacques E Rossouw; Garnet L Anderson
Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study.
American journal of epidemiology 2008;167(12):1407-15.
2008: Ross L Prentice; Rowan T Chlebowski; Marcia L Stefanick; JoAnn E Manson; Mary Pettinger; Susan Hendrix; F Allan Hubbell; Charles Kooperberg; Lewis H Kuller; Dorothy S Lane; Anne McTiernan; Mary Jo O'Sullivan; Jacques E Rossouw; Garnet L Anderson
Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
American journal of epidemiology 2008;167(10):1207-16.
2007: JoAnn E Manson; Matthew A Allison; Jacques E Rossouw; John Carr; Robert D Langer; Judith Hsia; Lewis H Kuller; Barbara B Cochrane; Julie R Hunt; Shari E Ludlam; Mary Pettinger; Margery Gass; Karen L Margolis; Lauren Nathan; Judith K Ockene; Ross L Prentice; John Robbins; Marcia L Stefanick
Estrogen therapy and coronary-artery calcification.
The New England journal of medicine 2007;356(25):2591-602.
2007: Jacques E Rossouw; Ross L Prentice; JoAnn E Manson; LieLing Wu; David Barad; Vanessa M Barnabei; Marcia Ko; Andrea Z LaCroix; Karen L Margolis; Marcia L Stefanick
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.
JAMA : the journal of the American Medical Association 2007;297(13):1465-77.
2007: Garnet L Anderson; Charles Kooperberg; Nancy Geller; Jacques E Rossouw; Mary Pettinger; Ross L Prentice
Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials.
Clinical trials (London, England) 2007;4(3):207-17.
2006: Jacques E Rossouw
Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease.
Annals of the New York Academy of Sciences 2006;1089():444-53.
2006: Garnet L Anderson; Rowan T Chlebowski; Jacques E Rossouw; Rebecca J Rodabough; Anne McTiernan; Karen L Margolis; Anita Aggerwal; J David Curb; Susan Hendrix; F Allan Hubbell; Janardan Khandekar; Dorothy S Lane; Norman L Lasser; Ana Maria Lopez; JoNell Potter; Cheryl Ritenbaugh
Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
Maturitas 2006;55(2):103-15.
2006: Susan Hendrix; Sylvia Wassertheil-Smoller; Karen C Johnson; Barbara V Howard; Charles Kooperberg; Jacques E Rossouw; Maurizio Trevisan; Aaron Aragaki; Alison E Baird; Paul F Bray; Julie E Buring; Michael H Criqui; David Herrington; John K Lynch; Stephen R Rapp; James Torner
Effects of conjugated equine estrogen on stroke in the Women's Health Initiative.
Circulation 2006;113(20):2425-34.
2005: Robert D Langer; Aruna D Pradhan; Cora E Lewis; JoAnn E Manson; Jacques E Rossouw; Susan Hendrix; Andrea Z LaCroix; Paul M Ridker
Baseline associations between postmenopausal hormone therapy and inflammatory, haemostatic, and lipid biomarkers of coronary heart disease. The Women's Health Initiative Observational Study.
Thrombosis and haemostasis 2005;93(6):1108-16.
2005: Jacques E Rossouw
Coronary heart disease in menopausal women: implications of primary and secondary prevention trials of hormones.
Maturitas 2005;51(1):51-63.
2004: Jacques E Rossouw
Trials for menopausal women.
The journal of the British Menopause Society 2004;10 Suppl 2():6.
2004: David D Waters; David Gordon; Jacques E Rossouw; Richard O Cannon; Peter Collins; David M Herrington; Judith Hsia; Robert Langer; Lori Mosca; Pamela Ouyang; George Sopko; Marcia L Stefanick
Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002 : Section 4: lessons from hormone replacement trials.
Circulation 2004;109(6):e53-5.
2004: Noel Bairey Merz; Robert O Bonow; George Sopko; Robert Balaban; Richard O Cannon; David F Gordon; Mary M Hand; Sharonne N Hayes; Jannet F Lewis; Terry Long; Teri A Manolio; Attilio Maseri; Elizabeth G Nabel; Patrice Desvigne Nickens; Carl J Pepine; Rita F Redberg; Jacques E Rossouw; Harry P Selker; Leslee J Shaw; David D Waters
Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: executive summary.
Circulation 2004;109(6):805-7.
2003: Jennifer Hays; Julie R Hunt; F Allan Hubbell; Garnet L Anderson; Marian C Limacher; Catherine Allen; Jacques E Rossouw
The Women's Health Initiative recruitment methods and results.
Annals of epidemiology 2003;13(9 Suppl):S18-77.
2003: JoAnn E Manson; Judith Hsia; Karen C Johnson; Jacques E Rossouw; Annlouise R Assaf; Norman L Lasser; Maurizio Trevisan; Henry R Black; Susan R Heckbert; Robert Detrano; Ora L Strickland; Nathan D Wong; John R Crouse; Evan Stein; Mary Cushman
Estrogen plus progestin and the risk of coronary heart disease.
The New England journal of medicine 2003;349(6):523-34.
2003: Sylvia Wassertheil-Smoller; Susan Hendrix; Marian C Limacher; Gerardo Heiss; Charles Kooperberg; Alison Baird; Theodore A Kotchen; J David Curb; Henry Black; Jacques E Rossouw; Aaron Aragaki; Monika Maria Safford; Evan Stein; Somchai Laowattana; W. Mysiw
Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial.
JAMA : the journal of the American Medical Association 2003;289(20):2673-84.
2002: Jacques E Rossouw
Hormones for coronary disease-full circle.
Lancet 2002;360(9350):1996-7.
2002: Aruna D Pradhan; JoAnn E Manson; Jacques E Rossouw; David S Siscovick; Charles P Mouton; Nader Rifai; Robert B Wallace; Rebecca D Jackson; Mary Pettinger; Paul M Ridker
Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.
JAMA : the journal of the American Medical Association 2002;288(8):980-7.
2002: Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith K Ockene
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
JAMA : the journal of the American Medical Association 2002;288(3):321-33.
2002: Jacques E Rossouw
Effect of postmenopausal hormone therapy on cardiovascular risk.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2002;20(2):S62-5.
2002: Jacques E Rossouw
Hormones, genetic factors, and gender differences in cardiovascular disease.
Cardiovascular research 2002;53(3):550-7.
1999: Jacques E Rossouw
Hormone replacement therapy and cardiovascular disease.
Current opinion in lipidology 1999;10(5):429-34.
1998: Jacques E Rossouw
Estrogen-progestin therapy was not effective in secondary prevention of CHD in post-menopausal women.
Evidence-based cardiovascular medicine 1998;2(4):96.